300601 on Shenzhen Stock Exchange
Shenzhen Kangtai Biological Products
Chinese biopharmaceutical company
Shenzhen Kangtai Biological Products (Chinese: 深圳康泰生物制品股份有限公司, SZSE: 300601), also known as BioKangtai (Chinese: 康泰生物), is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China.2 Wikipedia text CC BY-SA 4.0
Price unavailable
Last updated Oct 21, 2026.
Overview
- Ticker300601 on Shenzhen Stock Exchange1
- HeadquartersGuangzhou1
- Websitewww.biokangtai.com
- Legal formqi ye1
- LEI300300DTC3W6PCLFRJ053
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered address深圳市南山区科技工业园科发路6号, 510000 深圳市, China3
- Registered withState Administration for Market Regulation, 91440300618837873J3
See how the biggest companies compare on our leaderboards
Shenzhen Kangtai Biological Products (Chinese: 深圳康泰生物制品股份有限公司, SZSE: 300601), also known as BioKangtai (Chinese: 康泰生物), is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.2
Timeline
Links
- Websitewww.biokangtai.com1
- WikipediaShenzhen Kangtai Biological Products
- WikidataQ108113056
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3